Back to Archived Journals » Cell Health and Cytoskeleton » Volume 4

Sphingosine-1-phosphate signaling as a therapeutic target

Authors Giannoudaki, Swan, Kirby, Ali S

Received 19 May 2012

Accepted for publication 1 June 2012

Published 11 July 2012 Volume 2012:4 Pages 63—72


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 5

Eirini Giannoudaki, David J Swan, John A Kirby, Simi Ali

Applied Immunobiology and Transplantation Research Group, Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK

Abstract: Sphingosine 1-phosphate (S1P) is a small bioactive lipid molecule that is involved in several processes both intracellularly and extracellularly. It acts intracellularly to promote the survival and growth of the cell, through its interaction with molecules in different compartments of the cell. Extracellularly, it can exist at high concentrations in the blood plasma and lymph, further down inside the tissue. This causes an S1P gradient important for cell migration. S1P signals through five G protein-coupled receptors, S1PR1–S1PR5, whose expression varies in different types of cells and tissue. S1P signaling can be involved in physiological and pathophysiological conditions of the cardiovascular, nervous, and immune systems and diseases such as ischemia/reperfusion injury, autoimmunity, and cancer. In this review, we discuss this involvement and how it can be used to discover novel therapeutic targets.

Keywords: S1P, CD69, T-cell activation, lymph node, recirculation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]